Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$imrx](/topic/$imrx)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$imrx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$imrx/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XX% +16%  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-09-18  

**Most Supportive Themes**
- **Positive Valuation and Pipeline Advancements:** (40%) Posts highlight the undervaluation of $IMRX, citing strong revenue growth and advancements in its pipeline, particularly in oncology.
- **Insider Activity and Institutional Interest:** (30%) Mentions of insider buys and institutional investments, such as Fidelity and HBM Healthcare, suggest confidence in the company's future.
  
**Most Critical Themes**
- **Unclear if the company is a good investment:** (10%)  Some posts question the company's decisions and the rationale behind certain financial moves, such as the fundraising from SNY.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXX     | XX% | XX       | X% |
| YouTube | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXX     | XX% | XX       | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$imrx

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% +16%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-09-18

Most Supportive Themes

  • Positive Valuation and Pipeline Advancements: (40%) Posts highlight the undervaluation of $IMRX, citing strong revenue growth and advancements in its pipeline, particularly in oncology.
  • Insider Activity and Institutional Interest: (30%) Mentions of insider buys and institutional investments, such as Fidelity and HBM Healthcare, suggest confidence in the company's future.

Most Critical Themes

  • Unclear if the company is a good investment: (10%) Some posts question the company's decisions and the rationale behind certain financial moves, such as the fundraising from SNY.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXX XX% XX X%
YouTube X X% X X% X X%
Total XXXXX XX% XXX XX% XX X%
$imrx Sentiment
/topic/$imrx/sentiment